Ultime notizie per Lifezone Metals (NYSE:LZM) Azioni

Lifezone Metals

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises two segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary.

Lifezone Metals Ltd

Stock Repurchase Authorization: In November 2024, Zoom's Board of Directors authorized the repurchase of an additional $1.2 billion of Zoom's outstanding Class A common stock. This authorization is in addition to the amount remaining under the prior authorization for the share repurchase program, for a total of approximately $2.0 billion remaining to be repurchased.
Repurchases of Zoom's Class A common stock may be effected, from time to time, either on the open market (including pre-set trading plans), in privately negotiated transactions, and other transactions in accordance with applicable securities laws.
The timing and the amount of any repurchased Class A common stock will be determined by Zoom's management based on its evaluation of market conditions and other factors. The repurchase program will be funded using Zoom's working capital. Any repurchased shares of Class A common stock will be retired. The repurchase program does not obligate Zoom to acquire any particular amount of Class A common stock, and the repurchase program may be suspended or discontinued at any time at Zoom's discretion.

News

Buybacks

In November 2024, Zoom's Board Of Directors Authorized The Repurchase Of An Additional $1.2B Of Outstanding Class A Common Stock; Authorization Is In Addition To The Amount Remaining Under The Prior Authorization For The Share Repurchase Program, For A Total Of ~$2B Remaining To Be Repurchased

ALEC

Alector Reports Results From AL002 INVOKE-2 Phase 2 Trial In Individuals With Early Alzheimer's Disease; Says AL002 Failed To Meet Primary Endpoint

Financial Outlook:&nbsp;Zoom is providing the following guidance for its fourth quarter of fiscal year 2025 and its full fiscal year 2025.
<ul>
<li>Fourth Quarter Fiscal Year 2025: Total revenue is expected to be between $1.175 billion and $1.180 billion and revenue in constant currency is expected to be between $1.174 billion and $1.179 billion. Non-GAAP income from operations is expected to be between $443.0 million and $448.0 million. Non-GAAP diluted EPS is expected to be between $1.29 and $1.30 with approximately 315 million weighted average shares outstanding.</li>
<li>Full Fiscal Year 2025: Total revenue is expected to be between $4.656 billion and $4.661 billion and revenue in constant currency is expected to be between $4.661 billion and $4.666 billion. Full fiscal year non-GAAP income from operations is expected to be between $1.813 billion and $1.818 billion. Full fiscal year non-GAAP diluted EPS is expected to be between $5.41 and $5.43 with approximately 315 million weighted average shares outstanding. Full fiscal year free cash flow is expected to be between $1.580 billion and $1.620 billion.</li>
</ul>
The EPS and share count figures do not include the impact from the share repurchase authorization discussed below.
Additional information on Zoom's reported results, including a reconciliation of the non-GAAP results to their most comparable GAAP measures, is included in the financial tables below. A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future, although it is important to note that these factors could be material to Zoom's results computed in accordance with GAAP.
A supplemental financial presentation and other information can be accessed through Zoom's investor relations website at investors.zoom.us.

Guidance

Zoom Video Communications Sees Q4 EPS $1.29-$1.30 Vs $1.28 Est.; Revenue $1.175B-$1.18B Vs $1.17B Est.; FY25 EPS $5.41-$5.43 Vs $5.35 Est.; Revenue $4.656B-$4.661B Vs $4.64B Est.

Earnings

Earnings Beats

Earnings Misses

ENTA

Enanta Pharmaceuticals Sees Q4 2024 Revenue $14.6M Vs $17.9M Estimate; Sees Adj. EPS $-1.36 Vs $-1.16

Agilent Technologies Sees Q1 Adj. EPS $1.25-$1.28 Vs $1.37 Est.; Revenue $1.65B-$1.68B Vs $1.697B Est.

The Company expects to grant the underwriters a 30-day option to purchase up to 2.70 million additional shares of its common stock.
The Company intends to use the net proceeds of this offering together with cash on hand, including from recent sales under the Company's "at the market" offering program, to repay the $478.0 million mortgage loan with a fixed effective interest rate of approximately 9.0% and which is secured by its Washington Square property.

Offerings

Macerich Commences Public Offering Of 18M Shares Of Common Stock

PFLT

PennantPark Floating Rate Capital Ltd. Q4 Core NII Per Share $0.32

CLRO

ClearOne Engages ARC Group To Explore Strategic Alternatives Including Merger, Sale, Or Spin-Off To Maximize Shareholder Value, With Larry Hendricks Declining Re-Election To Board In 2024

Agilent Technologies Sees FY25 Adj. EPS $5.54-$5.61 Vs $5.66B Est.; Revenue $6.79B-$6.87B Vs $6.829B Est.

The approval is based on safety and effectiveness data from an Investigational Device Exemption (IDE) study and non-clinical testing for cementless partial knee replacement.
As part of the U.S. nationwide launch in Q1 2025, Zimmer Biomet will provide FDA-required training, focusing on the cementless surgical technique and proper patient selection.&nbsp;

Zimmer Biomet Reveals FDA Premarket Approval Application Supplement Approval For Oxford Cementless Partial Knee

Zoom Video Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $1.31 by 5.34 percent. This is a 6.98 percent increase over earnings of $1.29 per share from the same period last year. The company reported quarterly sales of $1.18 billion which beat the analyst consensus estimate of $1.16 billion by 1.16 percent. This is a 3.59 percent increase over sales of $1.14 billion the same period last year.

Zoom Video Comms Q3 Adj $1.38 Beats $1.31 Estimate, Sales $1.18B Beat $1.16B Estimate

CENT

CENTA

Central Garden & Pet Company Sees FY25 Non-GAAP EPS $2.20 Or Better

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) reported quarterly earnings of $1.46 per share which beat the analyst consensus estimate of $1.41 by 3.55 percent. The company reported quarterly sales of $1.700 billion which beat the analyst consensus estimate of $1.672 billion by 1.66 percent. This is a 0.71 percent increase over sales of $1.688 billion the same period last year.

Agilent Technologies Q4 2024 Adj. EPS $1.46 Beats $1.41 Estimate, Sales $1.700B Beat $1.672B Estimate

<h3>Gainers</h3>
<ul>
<li>Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) stock rose 19.2% to $36.6 during Monday's pre-market session. The company's market cap stands at $8.0 billion. As per the press release, Q3 earnings came out today. </li>
<li>Uxin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) shares increased by 16.74% to $7.37. The company's market cap stands at $1.3 billion. As per the news, the Q2 earnings report came out today. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) shares rose 16.48% to $1.13. The market value of their outstanding shares is at $39.1 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) shares increased by 14.15% to $0.77. The company's market cap stands at $10.7 million. </li>
<li>Alta Global Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock rose 11.7% to $1.87. The market value of their outstanding shares is at $19.5 million. </li>
<li>Premium Catering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PC#NASDAQ">PC</a>) shares rose 11.4% to $0.79. The market value of their outstanding shares is at $12.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock decreased by 8.8% to $23.01 during Monday's pre-market session. The company's market cap stands at $462.5 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares declined by 8.22% to $1.34. The company's market cap stands at $383.4 million. </li>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock decreased by 7.13% to $0.19. The market value of their outstanding shares is at $9.6 million. </li>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) shares fell 6.94% to $2.52. The company's market cap stands at $12.4 million. </li>
<li>Digital Brands Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) stock declined by 6.44% to $0.11. The market value of their outstanding shares is at $4.3 million. </li>
<li>Youdao (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAO#NYSE">DAO</a>) stock declined by 5.41% to $4.9. The market value of their outstanding shares is at $585.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BBWI

DBGI

ECDA

FTEL

NWTN

UXIN

12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Scholar Rock Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) stock rose 33.3% to $39.88 during Monday's pre-market session. The company's market cap stands at $3.7 billion. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) stock rose 22.88% to $0.43. The company's market cap stands at $15.2 million. </li>
<li>BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) stock rose 21.69% to $28.5. The company's market cap stands at $5.3 billion. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares increased by 19.69% to $22.0. The company's market cap stands at $47.7 million. </li>
<li>Mural Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MURA#NASDAQ">MURA</a>) stock increased by 17.01% to $3.92. The company's market cap stands at $66.8 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) stock moved upwards by 13.5% to $5.63. The company's market cap stands at $7.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) shares declined by 84.9% to $4.0 during Monday's pre-market session. The company's market cap stands at $192.4 million. </li>
<li>Oncternal Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCT#NASDAQ">ONCT</a>) stock declined by 28.95% to $0.81. The company's market cap stands at $2.3 million. </li>
<li>CareMax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares declined by 26.39% to $0.53. The market value of their outstanding shares is at $2.0 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) stock declined by 18.08% to $2.9. The company's market cap stands at $2.4 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares declined by 15.44% to $0.48. The market value of their outstanding shares is at $3.8 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) stock fell 14.13% to $0.09. The market value of their outstanding shares is at $7.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBIO

CMAX

EYEN

MURA

NKGN

ONCT

SAVA

SCNI

SINT

SRRK

VRPX

XCUR

12 Health Care Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock rose 54.5% to $2.55 during Monday's pre-market session. The market value of their outstanding shares is at $76.4 million. </li>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) stock moved upwards by 41.47% to $0.63. The company's market cap stands at $134.8 million. </li>
<li>Clean Energy Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) shares increased by 25.0% to $0.88. The company's market cap stands at $39.4 million. As per the press release, Q3 earnings came out 4 days ago. </li>
<li>Palladyne AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) shares increased by 18.69% to $5.46. The company's market cap stands at $164.4 million. </li>
<li>Lakeside Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) stock rose 13.88% to $3.69. The company's market cap stands at $27.6 million. </li>
<li>Ocean Power Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#AMEX">OPTT</a>) stock rose 11.94% to $0.17. The company's market cap stands at $22.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Diana Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DSX#NYSE">DSX</a>) stock declined by 14.0% to $1.84 during Monday's pre-market session. The company's market cap stands at $230.2 million. The company's, Q3 earnings came out today. </li>
<li>Xos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOS#NASDAQ">XOS</a>) shares decreased by 12.56% to $3.97. The market value of their outstanding shares is at $31.8 million. </li>
<li>Nano Nuclear Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) shares decreased by 10.99% to $29.91. The company's market cap stands at $996.6 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) stock declined by 10.57% to $0.93. The market value of their outstanding shares is at $22.9 million. </li>
<li>Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) shares declined by 10.03% to $15.8. The company's market cap stands at $70.8 million. </li>
<li>Polar Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POLA#NASDAQ">POLA</a>) stock fell 7.66% to $3.12. The company's market cap stands at $7.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CETY

KULR

OPTT

PDYN

POLA

TISI

VSTE

12 Industrials Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) shares increased by 50.0% to $13.7 during Monday's pre-market session. The market value of their outstanding shares is at $66.4 million. </li>
<li>Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) stock moved upwards by 49.47% to $2.6. The company's market cap stands at $500.1 million. </li>
<li>Brightcove (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCOV#NASDAQ">BCOV</a>) shares rose 35.69% to $4.33. The market value of their outstanding shares is at $195.3 million. </li>
<li>Unusual Machines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#AMEX">UMAC</a>) stock increased by 24.04% to $5.46. The market value of their outstanding shares is at $45.3 million. </li>
<li>NOVONIX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVX#NASDAQ">NVX</a>) stock rose 23.83% to $2.39. The company's market cap stands at $295.0 million. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) stock rose 22.95% to $7.5. The market value of their outstanding shares is at $886.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Wellchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) shares decreased by 21.7% to $1.55 during Monday's pre-market session. The market value of their outstanding shares is at $32.9 million. </li>
<li>AmpliTech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) shares declined by 19.36% to $1.0. The company's market cap stands at $11.0 million. </li>
<li>Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) shares fell 17.77% to $12.5. The company's market cap stands at $85.8 million. As per the press release, Q3 earnings came out today. </li>
<li>Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) stock fell 16.51% to $0.08. The market value of their outstanding shares is at $12.9 million. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock declined by 7.37% to $6.54. The company's market cap stands at $3.7 million. </li>
<li>Kingsoft Cloud Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) shares decreased by 6.8% to $6.72. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q3 earnings came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKTS

ALAR

AMPG

BCOV

Nuveen California Dividend Advantage Municipal Fund 2

QMCO

QUBT

RGTI

UMAC

12 Information Technology Stocks Moving In Monday's Pre-Market Session

Central Garden & Pet Q4 2024 Adj. EPS $(0.18) Beats $(0.20) Estimate, Sales $669M Miss $706.184M Estimate

WIIM

BLBD

Blue Bird shares are trading lower after the company reported mixed Q4 financial results and issued FY25 revenue guidance below estimates.

Woodward shares are trading higher after the company reported better-than-expected Q4 EPS and sales.

Warning: LZM is at high risk of performing badly

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Lifezone Metals (NYSE:<a href="https://investorplace.com/stock-quotes/lzm-stock-quote/">LZM</a>) just reported results for the second quarter of 2024.<ul><li>Lifezone Metals reported earnings per share of -9 cents.</li><li>The company reported revenue of $8,261.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	The post <a href="https://investorplace.com/earning-results/2024/08/lzm-stock-earnings-lifezone-metals-for-q2-of-2024/">LZM Stock Earnings: Lifezone Metals Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LZM Stock Earnings: Lifezone Metals Reported Results for Q2 2024

Lifezone Metals (LZM) has released an update. Grant Thornton has reviewed and concurred with the statements about their firm in Lifezone Metals Lim...

Lifezone Metals Auditor Approves Company Statements

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Lifezone Metals (NYSE:<a href="https://investorplace.com/stock-quotes/lzm-stock-quote/">LZM</a>) just reported results for the second quarter of 2024.<ul><li>Lifezone Metals reported earnings per share of -9 cents.</li><li>The company reported revenue of $8,261.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/lzm-stock-earnings-lifezone-metals-for-q2-of-2024/">LZM Stock Earnings: Lifezone Metals Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Press Releases

Lifezone Metals to Provide its Q1 2024 Operational Update and Financial Summary on Monday, May 13, 2024

Lifezone Metals Provides an Update on Operations and Unaudited Q1 2024 Financial Summary

Lifezone Metals Announces Voting Results from its 2024 Annual General Meeting

Lifezone Metals Advances Sustainable Battery Metal Production with Tanzanian Projects

Lifezone Metals Produces First-Ever Nickel, Copper and Cobalt from Kabanga Nickel Project

Lifezone Metals Operations Update and Half-Year 2024 Financial Results

Lifezone Metals Initiates Process for Risk Insurance with U.S. International Development Finance Corporation for the Kabanga Nickel Project in Tanzania

Lifezone Metals Announces Initiation of Project Financing Process for the Kabanga Nickel Project in Tanzania

Lifezone Metals and Japan Organization for Metals and Energy Security (JOGMEC) Sign Memorandum of Understanding

Commodities

Small Cap

Opinion

Record Investments Needed in Renewable Tech and Mining to Hit Global Emission Targets

Comments

Lifezone Metals

Notizie

Ultime notizie per Lifezone Metals (NYSE:LZM) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO